Tutorial: Speech Motor Chaining Treatment for School-Age Children With Speech Sound Disorders.
Jonathan L Preston, Megan C Leece, Jaclyn Storto
https://pubmed.ncbi.nlm.nih.gov/31051085/Actively Recruiting
Led by Syracuse University · Updated on 2026-01-13
84
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to compare two treatment schedules for children aged 9 to 17 with residual speech sound disorders, specifically targeting difficulties producing the and s sounds. The study focuses on how different treatment intensities affect speech sound learning in these children, who may face social, academic, and vocational challenges due to their speech difficulties. The trial evaluates theoretically motivated, motor-based treatments to find the most effective approach despite practical challenges. Participants will be randomly assigned to one of two groups an Intensive treatment schedule or a Distributed treatment schedule. The Intensive group receives Speech Motor Chaining therapy with 8 sessions in the first week, followed by fewer sessions over the next three weeks, totaling 16 hours in 4 weeks. The Distributed group receives the same total treatment hours spread over 8 weeks with two sessions per week. Treatment sessions use a web-based software to guide practice and feedback, focusing on eliciting and improving target speech sounds using motor learning principles. During the study, childrens speech will be assessed for accuracy before treatment and 10 weeks later by blinded listeners. Other measures include the proportion of responders and a survey on the speech disorders impact on social, emotional, and academic well-being. The study involves scheduled sessions, hearing screenings, language comprehension tests, and speech tasks to monitor progress. Participation lasts through treatment and follow-up assessments to evaluate outcomes and treatment effects.
CONDITIONS
Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders
J
Jonathan Preston, PhD
N
Nina Benway, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Syracuse University
Lead Sponsor
National Institutes of Health (NIH)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Intensive SMC | Distributed SMC |
|---|---|---|
| What it is | A structured motor-based behavioral therapy using Speech Motor Chaining delivered in an intensive schedule | Same Speech Motor Chaining procedure delivered over a distributed or extended schedule |
| Role in trial | Experimental delivery schedule being tested as one randomized arm | Experimental delivery schedule tested in the comparator arm |
| Primary use | Therapeutic intervention to improve accuracy of treated speech sounds | Therapeutic intervention to improve accuracy of treated speech sounds |
| How it is given or performed | Delivered in a concentrated, intensive schedule as defined in protocol | Delivered in a distributed schedule over time as defined in protocol |
| Evidence status | Preliminary evidence supports use of Speech Motor Chaining based on motor learning principles | Same Speech Motor Chaining content, evidence applies to technique not schedule |
| Important risks | Behavioral speech therapy methods generally have low risk; no serious risks reported | Behavioral speech therapy methods generally have low risk; no serious risks reported |
| Important limitations | Evidence exists for SMC as a method but not yet for differences between intensive vs distributed schedules | Evidence exists for SMC method but schedule effects not established |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 to 8 weeks depending on treatment schedule
Participants receive Speech Motor Chaining treatment delivered either intensively or distributed over several weeks to improve speech sound production.
Multiple sessions: either 8 sessions in Week 1 plus additional sessions over 3 weeks, or twice weekly visits for 8 weeks
Duration - Assessment at 10 weeks post treatment initiation
Participants return for assessments of speech sound production and survey evaluations approximately 10 weeks after the start of treatment.
1 follow-up visit (in-person)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jonathan L Preston, Megan C Leece, Jaclyn Storto
https://pubmed.ncbi.nlm.nih.gov/31051085/Syracuse University
Lead Sponsor
National Institutes of Health (NIH)
Collaborating Sponsor